Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward
E. J. Bell, Margherita Neri, Lotte Steuten
Applied Health Economics and Health Policy (2021) Vol. 20, Iss. 1, pp. 105-117
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0297608-e0297608
Open Access | Times Cited: 9
The implications of globalization on COVID-19 vaccination in Europe
Dan Lupu, Ramona Ţigănaşu
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant
Sophie Marbaix, Steven Simoens, Philippe Clevenbergh, et al.
Frontiers in Public Health (2025) Vol. 12
Open Access
The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy
Anna Puggina, Filippo Rumi, Eleftherios Zarkadoulas, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 212-212
Open Access
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
Ekkehard Beck, Eliana Biundo, Nancy Devlin, et al.
Vaccine (2022) Vol. 40, Iss. 30, pp. 4008-4016
Open Access | Times Cited: 21
Economic and cost-effectiveness aspects of vaccines in combating antibiotic resistance
Tatenda T. Yemeke, Hui-Han Chen, Sachiko Ozawa
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 10
The macroeconomic impact of a dengue outbreak: Case studies from Thailand and Brazil
Kinga Marczell, E. Ferrer García, Julie Roiz, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 6, pp. e0012201-e0012201
Open Access | Times Cited: 3
Which value aspects are relevant for the evaluation of medical devices? Exploring stakeholders’ views through a Web-Delphi process
Liliana Freitas, Ana Vieira, Mónica Duarte Oliveira, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the EU’s Regulation on HTA for Vaccines
Nathalie Largeron, Paolo D'Agostino, Ruth Chapman, et al.
Value in Health (2024) Vol. 27, Iss. 10, pp. 1318-1327
Closed Access | Times Cited: 3
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study
Manuela Di Fusco, Diana Mendes, Lotte Steuten, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 234-234
Open Access | Times Cited: 7
Meningococcal Disease in the Post–COVID-19 Era: A Time to Prepare
David E. Bloom, Paolo Bonanni, Federico Martinón‐Torres, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 12, pp. 2649-2663
Open Access | Times Cited: 6
Characterizing attributes of innovation of technologies for healthcare: a systematic review
M. Sakil Syeed, Nabin Poudel, Surachat Ngorsuraches, et al.
Journal of Medical Economics (2022) Vol. 25, Iss. 1, pp. 1158-1166
Open Access | Times Cited: 8
Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain
J. Mestre-Ferrandiz, Agustín Rivero, Alejandro Orrico‐Sánchez, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
New Vaccine Platforms—Novel Dimensions of Economic and Societal Value and Their Measurement
Philip O. Buck, Aparna Gomes, Ekkehard Beck, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 234-234
Open Access | Times Cited: 1
The economic and fiscal impact of incremental use of cell-based quadrivalent influenza vaccine for the prevention of seasonal influenza among healthcare workers in Italy
Giovanna Elisa Calabrò, Filippo Rumi, Roberto Ricciardi, et al.
Health Research Policy and Systems (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Invasive meningococcal disease in older adults: current perspectives and call for action
Catherine Weil-Olivier, Muhamed‐Kheir Taha, Sean X. Leng, et al.
European Geriatric Medicine (2024) Vol. 15, Iss. 3, pp. 729-741
Open Access | Times Cited: 1
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment
Frederick McElwee, Anthony T. Newall
PharmacoEconomics (2024) Vol. 42, Iss. S2, pp. 187-197
Open Access | Times Cited: 1
A Structured Narrative Literature Review of the Broader Value of Adult Immunisation Programmes
Hania El Banhawi, E. J. Bell, Margherita Neri, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 852-852
Open Access | Times Cited: 1
The value of vaccines
J.P. Sevilla
Current Opinion in Immunology (2022) Vol. 78, pp. 102243-102243
Closed Access | Times Cited: 7
Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility
Chris Skedgel, Patricia Cubí‐Mollá, David Mott, et al.
PharmacoEconomics - Open (2023) Vol. 7, Iss. 3, pp. 337-344
Open Access | Times Cited: 3
Value assessment of antimicrobials using the STEDI framework – How steady is the outcome?
Simon Brassel, Amer Al-Taie, Lotte Steuten
Health Policy (2023) Vol. 136, pp. 104892-104892
Open Access | Times Cited: 3
Capturing the value of vaccination: impact of vaccine-preventable disease on hospitalization
Mark Doherty, Emmanuel Aris, Nathalie Servotte, et al.
Aging Clinical and Experimental Research (2022) Vol. 34, Iss. 7, pp. 1551-1561
Open Access | Times Cited: 5
The Value of Vaccines: A Tale of Two Parts
Nathan A. Fox, Philip Adams, David Grainger, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2057-2057
Open Access | Times Cited: 5
Acceptance and application of a broad population health perspective when evaluating vaccine
Ulf Persson, Sara Olofsson, Rikard Althin, et al.
Vaccine (2022) Vol. 40, Iss. 24, pp. 3395-3401
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top